Kim Klement-USA TODAY Sports
Jason Hammel will look to stay healthy this year in an effort to earn a long-term deal.
2014 Free Agents
RHP Luis Ayala
RHP Jason Hammel
RHP Jim Johnson
LHP Tsuyoshi Wada
1B Conor Jackson
2B Brian Roberts
OF Nate McLouth
The Baltimore Orioles will have a decision to make regarding Johnson. He obviously came into his own last year as a closer and will be making $6.5 million this season.
Hammel comes at close to the same price tag ($6.75 million), and his future could be decided by his performance and by his health.
Roberts is almost certainly gone unless he agrees to a sizable decrease in pay. Wada signed a two-year, $8.15 million deal and has yet to throw a major league pitch. Unless he comes back later this season with a miraculous year following Tommy John surgery, he'll be looking for employment elsewhere.
Prospects Who Could Be Ready in 2014
RHP Dylan Bundy
RHP Kevin Gausman
RHP Mike Wright
2B Jonathan Schoop
OF L.J. Hoes
OF Xavier Avery
Bundy and Gausman could actually contribute this year, but there's no doubt both will be ready next season in case the O's decide not to re-sign Hammel or Wada.
Ditto with Hoes and Avery—with the injury histories of Reimold and Markakis, combined with just a one-year deal for McLouth, the Orioles have options in the outfield.
Schoop certainly appears to have all the tools to be a long-time force at second base as well, so Roberts' absence next season may not be a big deal.
Possible Free Agent/Trade Acquisitions
Considering how GM Dan Duquette has proceed in his 15 months on the job thus far, free agency is not the first priority, it's more a means of filling in the blanks. It's clear that Duquette is intent on building his team through its homegrown talent and by making prudent free-agent acquisitions.
Pitching would likely be the area that Duquette would go after. John Lannan could be an attractive option. Making just $2.5 million with the Washington Nationals this year, Lannan would fit nicely into the O's rotation with a strong year in Philadelphia.